N@N

Market Maker Surveillance Report. SDTH, BVTI, OXM, MATK, CMTL, ASTM, Losing Stocks With Lowest Price Friction For Thursday, De

^{Published on 2010-12-09 19:00:37, Last Modified on 2010-12-22 19:45:27 - WOPRAI}
 

December 9, 2010 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 2665 companies with "abnormal" market making, 3016 companies with positive Friction Factors and 2275 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Thursday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. SHENGDATECH INC (NASDAQ:SDTH), BIOVEST INTERNATIONAL INC (OTC:BVTI), OXFORD INDUSTRIES INC (NYSE:OXM), MARTEK BIOSCIENCES CORP (NASDAQ:MATK), COMTECH TELECOMMUNICATIONS (NASDAQ:CMTL), AASTROM BIOSCIENCES INC (NASDAQ:ASTM). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     SDTH       $-1.060      -17.32%      1,272,709       46.80%       1,432,767       52.69%       -160,058        -1,510  
     BVTI       $-0.180      -16.36%      225,201         34.13%       299,478         45.38%       -74,277         -4,127  
     OXM        $-4.590      -16.58%      440,457         43.25%       473,894         46.53%       -33,437         -73     
     MATK       $-2.770      -11.48%      711,821         45.39%       851,811         54.32%       -139,990        -505    
     CMTL       $-3.760      -11.96%      749,423         44.37%       934,407         55.33%       -184,984        -492    
     ASTM       $-0.670      -22.19%      420,869         36.32%       737,835         63.68%       -316,966        -4,731  

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows ASTM with a dollar loss Thursday of $-0.67000 and a Friction Factor of -4,731 shares. That means that it only took 4,731 more shares of selling than buying to move ASTM lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

SHENGDATECH INC (NASDAQ:SDTH) - ShengdaTech, Inc. engages in manufacturing, marketing, and selling nano precipitated calcium carbonate (NPCC) products in China. The company converts limestone into NPCC using its proprietary technology co-developed with Tsinghua University. It sells its products through a direct sales force. The company serves customers in the tire, polyvinyl chloride building materials, ink, paint, latex, adhesive, paper, and polyethylene industries. ShengdaTech also exports its products to Singapore, Thailand, South Korea, Malaysia, India, and Israel. The company was founded in 2005 and is based in Shanghai, China.

BIOVEST INTERNATIONAL INC (OTC:BVTI) - Biovest International, Inc., a biotechnology company, develops therapeutic anti-cancer vaccine for the treatment of low-grade Follicular Lymphoma in the United States. It develops BiovaxID, a Phase III clinical trial product, which is an injectable patient-specific vaccine to treat the follicular form of non-Hodgkins lymphoma. The company develops, manufactures, and markets cell culture systems, equipment, and consumable parts to pharmaceutical, diagnostic, and biotechnology companies, as well as to research institutions worldwide. Biovest International also produces mammalian and insect cells, monoclonal antibodies, recombinant and secreted proteins, and other cell culture products using hollow fiber perfusion. It is also developing an automated cell culture instrument, AutovaxID that enables production of personalized cell-based treatments. In addition, the company sells hollow fiber bioreactors, cultureware, tubing sets, and other disposable products and supplies. Further, Biovest International engages in the production and contract manufacture of biologic drugs and cell production for research institutions. Its customers include biopharmaceutical and biotech companies, medical schools, universities, research facilities, hospitals, and public and private laboratories. The company was incorporated in 1981 as Endotronics, Inc. and changed its name to Cellex Biosciences, Inc. in 1993. Further, it changed its name to Biovest International, Inc. in 2001. The company is based in Tampa, Florida. Biovest International, Inc. is a subsidiary of Accentia Biopharmaceuticals, Inc. On November 10, 2008, Biovest International Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida, Tampa, in joint administration with Accentia Biopharmaceuticals, Inc.

OXFORD INDUSTRIES INC (NYSE:OXM) - Oxford Industries, Inc. engages in the design, production, sale, and distribution of branded and private label apparel for men and women primarily in the United States and the United Kingdom. The companys products include branded and private label dress shirts, suited separates, sport shirts, casual slacks, outerwear, sweaters, jeans, swimwear, westernwear, and golf apparel products, as well as tailored clothing products and accessories. Its brands include Tommy Bahama, Ben Sherman, Ely, Nickelson, Cattleman, Oxford Golf, Cumberland Outfitters, Arnold Brant, and Billy London. The company also holds licenses to produce and sell various categories of apparel products under the Kenneth Cole, Dockers, Geoffrey Beene, and United States Polo Association brand names. Its third party license arrangements for its Tommy Bahama products include mens and womens watches, eyewear, belts and socks, and fragrances; shampoo, soap, and bath amenities; ceiling fans; rugs; wallcoverings; luggage; indoor and outdoor furniture; bedding and bath linens; and table top accessories. The companys third party license arrangements for Ben Sherman products comprise footwear, kids apparel, backpacks, travel bags, suits, dress shirts, watches, jewelry, underwear, socks, sleepwear, eyewear, gift products, fragrances, toiletries, accessories, wallets, small leather goods, neckwear, pocket squares, hats, caps, scarves, gloves, and belts. It primarily distributes its products through wholesale distribution channels, including national chains, department stores, mass merchants, specialty stores, specialty catalog retailers, and Internet retailers, as well as through its owned and licensed retail stores and e-commerce Websites. In addition, the company operates restaurants. Oxford Industries was founded in 1942 and is based in Atlanta, Georgia.

MARTEK BIOSCIENCES CORP (NASDAQ:MATK) - Martek Biosciences Corporation engages in the development and commercialization of nutritional products from microbial sources, including algae, fungi, and other microbes worldwide. Its products include life'sDHA, a vegetarian source of algal DHA omega-3 important for brain, heart, and eye health throughout life, as well as for use in foods, beverages, infant formula, and supplements; and life'sARA, an omega-6 fatty acid, for use in infant formula and growing up milks. In addition, the companys subsidiary, Amerifit Brands, Inc. develops, markets, and distributes branded consumer health and wellness products in mass, club, drug, grocery, and specialty stores. Its products include Culturelle, a probiotic supplement; AZO, an OTC brand addressing symptom relief, detection, and prevention of urinary tract infections; and ESTROVEN, a nutritional supplement brand addressing the symptoms of menopause. Martek Biosciences Corporation also provides contract manufacturing services for the production of enzymes, specialty chemicals, vitamins, and agricultural specialty products. It sells oils containing fatty acids under the names of life'sDHA, DHASCO, Neuromins, ARASCO, and life'sARA. The company markets its nutritional oils primarily to the infant formula, pregnancy and nursing, food and beverage, dietary supplement, and animal feed markets. Martek Biosciences Corporation was founded in 1985 and is headquartered in Columbia, Maryland.

COMTECH TELECOMMUNICATIONS (NASDAQ:CMTL) - Comtech Telecommunications Corp. designs and produces a wide range of telecom systems and services. The companys telecom transmission division markets such products as satellite earth station equipment and over-the-horizon microwave systems. The mobile data communications department offers mobile satellite transceivers and satellite packet data networks. Comtech also manufactures broadband amplifiers in the microwave and radio frequency spectrums. Its amplifiers are used in both defense and commercial applications. Apart from providing the hardware, the company also provides installation, training, and maintenance. Comtech, which was founded in 1967, is headquartered in Melville (N.Y.).

AASTROM BIOSCIENCES INC (NASDAQ:ASTM) - Aastrom Biosciences, Inc. engages in developing autologous cell products for the treatment of severe, chronic, and cardiovascular diseases. The company's proprietary tissue repair cell (TRC) technology expands the numbers of stem and early progenitor cells from a small amount of bone marrow collected from the patient. The company is conducting a Phase II cardiac regeneration clinical trial (the IMPACT-DCM trial) in patients with dilated cardiomyopathy (DCM severe chronic heart failure) and a Phase IIb vascular regeneration clinical trial (the RESTORE-CLI trial) in patients with critical limb ischemia (CLI the most severe form of peripheral arterial disease). Aastrom Biosciences would also initiate its U.S. Phase II clinical trial to evaluate the catheter delivery of CRCs for the treatment of DCM. The company was founded in 1989 and is headquartered in Ann Arbor, Michigan.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net